Clinical trial

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

NCT01222611

Study summary

ClinicalTrials.gov

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Fosamprenavir Normalized identity: fosamprenavir View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE4

Conditions

Chronic HIV Infectionunresolved

HCV Coinfectionunresolved

Interventions

FosamprenavirDRUG · verified · RxNorm: fosamprenavir

Sponsors & collaborators

Fundacion SEIMC-GESIDAlead sponsor

ViiV Healthcarecollaborator

Mapped research locations

MadridMadrid, Spain5 Alcalá de HenaresMadrid, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01222611 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.